Home › Funds › Royce & Associates › ACA
Royce & Associates position in ACA
ARCOSA INC · Industrials
Royce & Associates reported holding 698,327 shares of ACA (ARCOSA INC) in its Q3 2026 13F filing — a position valued at US$102.1M, representing 0.93% of its reported portfolio and ranking #3 among its reported holdings. Royce & Associates has disclosed ACA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Royce & Associates's ACA position evolved
Royce & Associates first disclosed a stake in ACA in Q3 2021 at 1,628,149 shares (US$81.7M). The position peaked in Q2 2026 at 993,710 shares, worth US$144.4M. Across 21 filings, Royce & Associates increased the stake 7 time(s), trimmed it 11 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 698,327 shares valued at US$102.1M — a reduction of -295,383 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.63M | $81.68M | New |
| Q4 2021 | 1.80M | $94.73M | Add |
| Q1 2022 | 1.90M | $108.67M | Add |
| Q2 2022 | 1.95M | $90.52M | Add |
| Q3 2022 | 1.74M | $99.25M | Reduce |
| Q4 2022 | 1.53M | $83.22K | Reduce |
| Q1 2023 | 1.47M | $92.96K | Reduce |
| Q2 2023 | 1.42M | $107.92M | Reduce |
| Q3 2023 | 1.40M | $100.88M | Reduce |
| Q4 2023 | 1.46M | $120.58M | Add |
| Q1 2024 | 1.43M | $122.55M | Reduce |
| Q2 2024 | 1.43M | $119.19M | Hold |
| Q3 2024 | 1.37M | $129.61M | Reduce |
| Q4 2024 | 1.24M | $119.88M | Reduce |
| Q1 2025 | 1.25M | $96.72M | Add |
| Q2 2025 | 1.26M | $109.47M | Add |
| Q3 2025 | 1.27M | $118.74M | Hold |
| Q4 2025 | 1.23M | $131.25M | Reduce |
| Q1 2026 | 1.25M | $132.92M | Add |
| Q2 2026 | 993.71K | $144.38M | Reduce |
| Q3 2026 | 698.33K | $102.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACA and 13F data
ACA (ARCOSA INC) is a Industrials company. 35 other funds we track also report a position in ACA — the largest reported positions include Pentwater Capital Management LP (US$306.9M), Balyasny Asset Management (US$172.4M), AQR Arbitrage LLC (US$108.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACA
- Pentwater Capital Management LP 2.10M sh · $306.92M · Q3 2026
- Balyasny Asset Management 1.18M sh · $172.40M · Q3 2026
- AQR Arbitrage LLC 742.39K sh · $108.50M · Q3 2026
- ROYCE & ASSOCIATES LP 698.33K sh · $102.06M · Q3 2026
- TUDOR INVESTMENT CORP ET AL 586.97K sh · $85.79M · Q3 2026
- Magnetar Financial LLC 572.54K sh · $83.68M · Q3 2026
- Soros Fund Management 545.94K sh · $79.79M · Q3 2026
- CAXTON ASSOCIATES LLP 464.10K sh · $67.83M · Q3 2026
- Hudson Bay Capital Management LP 386.30K sh · $56.46M · Q3 2026
- Westchester Capital Management, LLC 372.61K sh · $54.46M · Q3 2026
More on Royce & Associates
FAQ
How long has Royce & Associates held ACA?
Royce & Associates has disclosed ACA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Royce & Associates's current position in ACA?
As of Q3 2026, Royce & Associates holds 698.33K shares of ACA (ARCOSA INC), valued at $102.06M, representing 0.93% of its reported portfolio and ranking #3.
Has Royce & Associates been buying or selling ACA?
In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in ACA. The position peaked in Q2 2026 at 993.71K shares.
Which other funds hold ACA?
Other major institutional holders of ACA include Pentwater Capital Management LP, Balyasny Asset Management, AQR Arbitrage LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.